Melanoma-associated retinopathy: A presenting sign of metastatic disease

Journal of the American Academy of Dermatology

Volumn 65, Issue 1, 2011, Pages

  Handler, Marc Z ^a   Mruthyunjaya, Prithvi ^b   Nelson, Kelly ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE; TRIAMCINOLONE ACETONIDE;

ADULT; ANAMNESIS; BIOMICROSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ELECTRORETINOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MELANOMA; METASTASIS; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETINOPATHY; TREATMENT RESPONSE; VISUAL ACUITY; WESTERN BLOTTING;

EID: 79958854121     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.09.015     Document Type: Article

References (5)

1. Keltner J, Thirkill C, Yip P. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuro-Ophthamol 2001;21:173-87. (Pubitemid 33028979)
2. Pfohler C, Haus A, Palmowski A, Ugurel S, Ruprecht KW, Thirkill CE, et al. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma. Br J Dermatol 2003;149:74-8. (Pubitemid 36966513)
3. Chan C, O'Day J. Melanoma-associated retinopathy: does autoimmunity prolong survival? Clin Exp Ophthalmol 2001;29:235-8.
4. Jacobzone C, Cochard-Marianowski C, Kupfer I, Bettembourg S, Dordain Y, Misery L, et al. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings. Arch Dermatol 2004;140:1258-61. (Pubitemid 39362245)
5. Ferreyra HA, Jayasundera T, Khan NW, He S, Lu Y, Heckenlively JR, et al. Management of autoimmune retinopathies with imunosuppression. Arch Ophthalmol 2009;127:390-7.